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The human immunoglobulin G (IgG) 2G12 recognizes
high-mannose carbohydrates on the HIV type 1
(HIV-1) envelope glycoprotein gp120. Its two anti-
gen-binding fragments (Fabs) are intramolecularly
domain exchanged, resulting in a rigid (Fab)2 unit
including a third antigen-binding interface not found
in antibodies with flexible Fab arms. We determined
crystal structures of dimeric 2G12 IgG created by
intermolecular domain exchange, which exhibits
increased breadth and >50-fold increased neutrali-
zation potency compared with monomeric 2G12.
The four Fab and two fragment crystalline (Fc) re-
gions of dimeric 2G12 were localized at low resolu-
tion in two independent structures, revealing IgG
dimers with two (Fab)2 arms analogous to the Fabs
of conventional monomeric IgGs. Structures re-
vealed three conformationally distinct dimers,
demonstrating flexibility of the (Fab)2-Fc connec-
tions that was confirmed by electron microscopy,
small-angle X-ray scattering, and binding studies.
We conclude that intermolecular domain exchange,
flexibility, and bivalent binding to allow avidity effects
are responsible for the increased potency and
breadth of dimeric 2G12.INTRODUCTION
Difficulties in generating broadly neutralizing antibodies against
HIV type 1 (HIV-1) lie in structural features of the gp120-gp41 en-
velope spike trimer (Bartesaghi et al., 2013; Julien et al., 2013;
Lyumkis et al., 2013). Briefly, the spike’s variable loops are highly
susceptible to rapid mutation (Starcich et al., 1986), its fewCell Reconserved regions are often sterically occluded via conforma-
tional masking (Kwong et al., 2002), and a host-derived glycan
shield covers much of the spike surface, making gp120 one of
the most heavily glycosylated proteins in nature (Poignard
et al., 2001). As such, surface carbohydrates contribute to
roughly 50% of gp120’s molecular weight (Botos andWlodawer,
2005). Despite the fact that most antibodies elicited against
HIV-1 are strain-specific, there exists a small set of broadly
neutralizing antibodies that have demonstrated efficacy across
strains (Kwong and Mascola, 2012; Mascola and Haynes,
2013). Isolated from the blood of infected individuals, these
antibodies have been found to target conserved epitopes on
either the gp120 or gp41 subunits of the envelope spike protein.
Human monoclonal antibody 2G12 recognizes clusters of
N-linked high-mannose (Man8-9GlcNAc2) glycans on the surface
of gp120 (Calarese et al., 2005; Sanders et al., 2002; Scanlan
et al., 2002) and effectively neutralizes many clade B and some
clade A strains of HIV-1 (Trkola et al., 1996). 2G12’s ability to
target glycan clusters is facilitated by three-dimensional domain
swapping (Liu and Eisenberg, 2002) of its heavy chains to form a
rigid (Fab)2 antigen-binding unit (Calarese et al., 2003). By
contrast, two independent antigen-binding units are found in
conventional immunoglobulin Gs (IgGs), which contain two
heavy chains and two light chains arranged into two Fab regions
and a single fragment crystalline (Fc) region (Figure 1A). In a
typical Fab, the two domains of the light chain, the variable light
(VL) and constant light (CL) domains, pair with the variable heavy
(VH) and constant heavy 1 (CH1) domains, respectively, of a sin-
gle heavy chain. In the domain-swapped (Fab)2 unit of mono-
meric 2G12, each light chain is associated with both heavy
chains, such that the CL domain of a light chain contacts CH1
from one heavy chain and the VL domain from that light chain
contacts the VH domain from the second heavy chain. The result
is a single rigid (Fab)2 unit that contains a third antigen-binding
site at the VH/VH
0 interface in addition to the two primary anti-
gen-binding sites formed by the VH/VL interfaces (Figure 1B).
The unique VH/VH
0 site allows for increased glycan contacts atports 5, 1443–1455, December 12, 2013 ª2013 The Authors 1443
Figure 1. Schematic IgG Structures
Heavy chains (identical polypeptide chains but
colored differently for illustrating domain swap-
ping) are cyan and yellow, light chains are gray,
and antigen-binding sites are shown as starbursts.
(A) Conventional IgG with flexible Fab arms and
two antigen-binding sites at the VH/VL interfaces.
(B) 2G12 monomer with domain-swapped (Fab)2
unit and an additional antigen-binding site at the
VH/VH
0 interface.
(C) 2G12 dimer with two domain-swapped (Fab)2
units and six antigen-binding sites.
See also Figure S1.the binding surface of 2G12, allowing it to target densely clus-
tered carbohydrates that might be inaccessible to conventional
immunoglobulin G (IgG) antibodies (Calarese et al., 2003).
During purification of recombinant 2G12, we previously found
that 2G12 formed monomers (two Fabs and one Fc) plus a small
fraction of a higher-molecular-weight species, which was 50- to
80-fold more potent than 2G12 monomer in neutralization of
clade A and B HIV-1 (West et al., 2009). This species, identified
as 2G12 dimer (four Fabs and two Fcs), was proposed to form
through intermolecular domain swapping rather than the intra-
molecular domain swapping that results in 2G12 monomer
(Figures 1C and S1A). Both monomer and dimer were produced
during expression inmammalian cells and could be separated by
size-exclusion chromatography into purified samples that did
not interconvert upon storage or concentration.
Because 2G12 dimer is extremely potent and some 2G12
monomer-resistant HIV strains were neutralized by dimer, in-
creasing the proportion of 2G12 dimer could lead to a more
effective reagent for gene therapy or passive immunization.
Indeed, introduction of a higher dimer/monomer ratio 2G12 cell
line (West et al., 2009) into HIV-1-infected humanized mice
increased protection against infection compared with the wild-1444 Cell Reports 5, 1443–1455, December 12, 2013 ª2013 The Authorstype 2G12-expressing cell line, and injec-
tion of 2G12 dimer, but not monomer,
controlled HIV-1 infection in mouse
models (Luo et al., 2010). In addition to
its increased capacity for antigen recog-
nition, 2G12 dimer also has the potential
for protection via effector functions
because it can mediate antibody-depen-
dent cellular cytotoxicity (ADCC) in vitro
(Klein et al., 2010), indicating that it re-
tains binding to the CD16 Fc receptor
on natural killer cells despite its unusual
structure.
To investigate the structural and mech-
anistic basis of the increased potency of
2G12 dimer compared with the mono-
mer, we solved two independent, low-
resolution structures of 2G12 dimer by
X-ray crystallography. We performed
several structural validations to confirm
the 2G12 dimer structures. Collectively,
the structures revealed three conforma-tionally distinct forms of the dimer, suggesting that the two
(Fab)2 units can adopt different positions relative to the Fcs, anal-
ogous to the flexibility of the two Fab arms of a conventional IgG.
Consistent with the crystal structures, electron microscopy and
small-angle X-ray scattering studies confirmed the flexible na-
ture of 2G12 dimer. Additionally, we showed that 2G12 dimer,
but not 2G12 monomer, could bind bivalently to immobilized
gp120 in a biosensor assay and confirmed that both Fc regions
in the 2G12 dimer were accessible to an Fc receptor using bind-
ing and stoichiometry measurements. Our results provide a
structural explanation for the superior neutralization potency of
2G12 dimer compared with monomer (West et al., 2009) and
rationalize the dimer’s ability to mediate Fc-mediated effector
functions (Klein et al., 2010).
RESULTS
Crystallization and Structure Determination of 2G12
Dimer
Structure determinations of intact antibodies are inherently
limited by flexibility between domains and, in the case of 2G12,
the existence of multiple oligomeric states. Despite these
Figure 2. Packing in 2G12 Dimer Crystals
(A) Asymmetric unit of a solvent-flattened 8.0 A˚ resolution 2Fo-Fc electron density map contoured at 1.5 s. The asymmetric unit contained three half-dimers;
i.e., three Fc regions and three (Fab)2 units from three distinct 2G12 dimers (A, B, and C). Crystal contacts involved the antigen-binding sites in the (Fab)2 units
(green circles); see also Figure S2.
(B) Application of symmetry operators to generate the second half of each 2G12 dimer. Dimer A (cyan) was structurally distinct from dimers B (magenta) and C
(indigo), which exhibited the same conformation.
(C) Noncrystallographic 6-fold symmetry axis showing a hexamer of Fc regions coincident with the 61 screw axis along the crystallographic c axis. The asym-
metric unit is highlighted in yellow.
(D) The three dimers in one layer of the crystal, represented by the cyan, magenta, and indigo dimers A, B, and C from (B), as they fit into the Fc hexamer ring in (C);
see also Figure S2.challenges, we were able to readily obtain crystals of intact
purified 2G12 dimer. The best crystals (space group P6122) dif-
fracted to only 7.4 A˚ (Table S1) despite optimizing crystallization
conditions and screening >500 crystals.We obtained preliminary
phases using molecular replacement with the 2G12 (Fab)2 (Pro-
tein Data Bank [PDB] entry 1OP3) and IgG Fc (PDB entry 1H3X)
structures as search models and verified the solution using
heavy-atom derivative data (Figures 2 and S2; Table S1; Supple-
mental Experimental Procedures). Three 2G12 (Fab)2 units were
initially located in the crystallographic asymmetric unit (Fig-
ure 2A). The Fc regions were found only in molecular replace-
ment searches involving a fixed partial solution including the
(Fab)2 units. CrystallographicR values after rigid body and B fac-
tor domain refinement decreased from 0.50 to 0.37 after placing
the Fc regions. The final model at 8.0 A˚ resolution (Rwork = 0.35;Cell ReRfree = 0.37; Table S1) contained three (Fab)2 units and three Fc
regions representing three separate half-dimers (Figure 2A).
Applying crystallographic 2-fold symmetry operations generated
three physiological 2G12 dimers, each with two (Fab)2 units and
two Fc regions (Figure 2B). The (Fab)2 units of the 2G12 dimers
contacted each other at their antigen-binding sites (Figure 2A).
They were flanked by pairs of Fc regions that formed a hexamer
via a 6-fold noncrystallographic symmetry (NCS) axis coincident
with a crystallographic 61 screw axis (Figure 2C). The Fc regions
forming the hexamers contacted each other at the hinge
between the CH2 and CH3 domains, the so-called ‘‘hot spot’’
on IgG Fc for interactions with receptors and other proteins
(DeLano et al., 2000).
The placement of the (Fab)2 and Fc regions in the P6122 unit
cell was dependent upon NCS relating the three half-dimers inports 5, 1443–1455, December 12, 2013 ª2013 The Authors 1445
Figure 3. Native Patterson Validation of Packing in 2G12 Dimer Crystals
(A and B) Native Patterson maps. Comparison of experimental and calculated Harker sections.
(C) Two layers of 2G12 dimermolecules as they are packed into the P6122 crystals. Left: top-down view showing the cyan (dimer A), magenta (dimer B), and indigo
(dimer C) 2G12 dimers (Figure 2) in the same layer. The magenta and indigo dimers are conformationally identical, and the cyan dimer is distinct. The layer below
contains three additional dimers (light green, light pink, and light blue), formed via a rotation and translation along the crystallographic 61 axis. Symmetry mates
are indicated as a darker and lighter version of the same color. Right: a 90 rotation showing hexamer of Fc regions in the middle layer.
See also Figure S3.the crystallographic asymmetric unit, which we sought to vali-
date to confirm model accuracy. A self-rotation function yielded
no peaks for NCS (data not shown). However, NCS axes that are
parallel to crystallographic axes of the same or higher symmetry
are not detected in self-rotation functions because their peaks
coincide with peaks corresponding to crystallographic axes
(Rupp, 2010). An NCS axis parallel to a crystallographic can be
detected as a peak in a native Patterson map (Rupp, 2010). A
native Patterson calculated using the 8 A˚ P6122 data showed
peaks at positions 1/6, 1/3, and 1/2 along the w axis (Figures
3A and 3B). These peaks resulted from the 6-fold rotational
NCS axis formed by the hexamer of Fc regions along the crystal-
lographic 61 screw axis (Figure 3C). Structure factors calculated
from themodel of 2G12 half-dimers in the P6122 asymmetric unit
reproduced these peaks in a native Patterson calculation (Fig-
ures 3A and 3B), validating the placement of the (Fab)2 and Fc
regions in the low-resolution 2G12 dimer structure.1446 Cell Reports 5, 1443–1455, December 12, 2013 ª2013 The AutOverall Structure of 2G12 Dimer
Two of the 2G12 dimers (dimers B and C) in the P6122 crystals
were conformationally identical, whereas the third dimer
(dimer A) was distinct (Figures 4A, 4B, S4A, and S4B). The
(Fab)2 arms of dimers B and C were related by an angle of
100, similar to a typical angle between a pair of Fab arms in
a conventional, non-domain-swapped IgG antibody (Roux,
1999), and the (Fab)2 arms of dimer Awere related by180 (Fig-
ures 4A and 4B). The difference in relative positions of the (Fab)2
arms is consistent with flexibility between the two (Fab)2 portions
of the 2G12 dimer structure, in contrast to the inflexibility of the
single rigid (Fab)2 of 2G12 monomer. The span between the
combining sites of the two (Fab)2 arms of 2G12 dimers, ranging
from 105 to 170 A˚, was similar to the combining sites of the two
Fab arms of a conventional IgG, which are separated by 150 A˚
(Klein and Bjorkman, 2010). These findings suggest that 2G12
dimer exhibits enhanced neutralization potency due to its abilityhors
Figure 4. Structures of the Three Distinct 2G12 Dimers from Two Independent Crystal Structures
Dimer structures are shown as 25 A˚ electron density envelopes calculated from (Fab)2 and Fc coordinates located by molecular replacement. The approximate
distance between the tips of the (Fab)2 units of each dimer is shown on the left.
(A) Dimer A, one of two conformationally distinct 2G12 dimers in the P6122 2G12 dimer structure. Middle and right: Heavy chains are cyan and yellow, light chains
are transparent gray. Middle: Top-down view of the 2G12 dimer with Fc regions pointing into the page. Right: Two rotated views showing the large distance
between (Fab)2 units and Fc regions and an angle of 180
 between (Fab)2 arms.
(B) Dimers B and C, the second of the two distinct 2G12 dimers in the P6122 2G12 dimer structure. Middle and right: Heavy chains are magenta, indigo, light pink,
or light blue; light chains are transparent gray.Middle: Top-down view of the 2G12 dimermolecule with Fc regions pointing into the page. Right: Two rotated views
showing an obtuse angle between (Fab)2 units.
(C) 2G12 dimer in crystals of 2G12 bound to the 2G12.1 peptide.Middle and right: Heavy chains are orange, green, light orange, or light green; light chains are light
gray. Middle: Top-down view. The two (Fab)2 units are extended at 180
 with respect to each other, as are the two Fc regions (not seen in this view). Right: Two
rotated views showing the Fc regions under the (Fab)2 units.
See also Figure S4.to bind HIV spikes bivalently with flexible (Fab)2 arms, as
compared with 2G12monomer, which binds monovalently using
a single (Fab)2 arm.Cell ReOur data also support amechanism for creating IgG dimers via
three-dimensional (3D) domain swapping. In this model, each Fc
is a hybrid, with each chain derived from a different monomerports 5, 1443–1455, December 12, 2013 ª2013 The Authors 1447
(Figure S1A). The heavy-chain portions of each (Fab)2 unit in the
2G12 dimer each pair with the CH2-CH3 region (i.e., the Fc) ex-
tending from a neighboring (Fab)2. As in other intact IgG struc-
tures (Guddat et al., 1993; Harris et al., 1997, 1998; Kratzin
et al., 1989; Saphire et al., 2001), the hinge regions of the 2G12
dimers were not resolved in the electron density maps. However,
the orientation of the Fc regions in the three 2G12 dimers sup-
ported the connectivity model. The model was also consistent
with the propensity of 2G12 to form higher-order oligomers,
including trimers (Figure S1B), which were evident in size-exclu-
sion chromatography profiles of 2G12 (Figure S1C).
Crystallization and Structure Determination of 2G12
Dimer/2G12.1 Peptide Complex
Packing in the P6122 2G12 dimer crystals involved contacts
between the antigen-binding sites of adjacent (Fab)2 units (Fig-
ure 2A). We reasoned that disrupting these contacts could allow
2G12 dimer to crystallize in a different packing arrangement that
might diffract to higher resolution. To that end, we crystallized
2G12 dimer in the presence of 2G12.1, a 21-residue synthetic in-
hibitor peptide that binds to the combining site of 2G12 (Fab)2
(Menendez et al., 2008). We solved the 2G12 dimer/2G12.1 pep-
tide complex structure in space group P6 to 6.5 A˚ using molec-
ular replacement (Table S1). The angle between the (Fab)2 units
and Fcs in the 2G12 dimer in this crystal form (Figure 4C) was
different from either dimer A or dimer B in the P6122 2G12 dimer
crystals (Figures 4A and 4B); thus, molecular replacement
worked only when we used separate (Fab)2 and Fc search
models, resulting in an R value decrease from 0.45 to 0.40 after
the Fc region was correctly introduced into the model. Although
low resolution precluded visualization of the 2G12.1 peptide in
the antigen-binding site, introduction of the peptide altered the
packing such that there were no crystal contacts involving the
(Fab)2 antigen-binding site (Figure S3A). However, the Fc regions
of 2G12 dimer were arranged as hexamers in the 2G12/2G12.1
crystals (Figure S3B), as also found in the packing of the 2G12
dimer crystals (Figures 2C and 3C).
It was initially difficult to determine the connectivity between
the (Fab)2 and Fc regions of the 2G12 dimer in the 2G12/
2G12.1 structure because the Fc regions were arranged almost
parallel to the (Fab)2 units (Figure 4C). The (Fab)2-Fc connec-
tions in the 2G12 dimer/2G12.1 complex structure were inter-
preted by assigning probable connectivity between the N
termini of the four heavy chains of the two Fc regions and the
C termini of the four heavy chains of the two (Fab)2 units. Using
the shortest combinations of distances as the most plausible
choice for connectivity between the chains (see Supplemental
Results), we derived the same hybrid Fc model of intermolecular
domain exchange as deduced for the formation of the 2G12
IgG dimer (Figure S1A). Assuming this connectivity, the 2G12
dimer in the 2G12/2G12.1 crystal structure adopted a confor-
mation distinct from the two found in the 2G12-dimer-alone
structure: The Fc regions were oriented at 180 with respect
to each other and were essentially parallel to the (Fab)2 units,
which were also splayed 180 apart (Figure 4C), similar to
dimer A from the P6122 structure (Figure 4A). Comparison of
the three 2G12 dimer conformations obtained from the 2G12
dimer and 2G12 dimer/2G12.1 complex structures demon-1448 Cell Reports 5, 1443–1455, December 12, 2013 ª2013 The Autstrated a large range of conformations accessible to the 2G12
dimer (Figures 4 and S4).
Electron Microscopy Studies of 2G12 Dimer and
Higher-Order Oligomers
We studied the different fractions eluted from a size exclusion
chromatography (SEC) purification (Figure S1C) that corre-
sponded in apparent molecular weights to 2G12 monomer,
dimer, and trimer by negative-stain electron microscopy (EM)
and reference-free two-dimensional (2D) classification. Refer-
ence-free 2D classes for each of the 2G12 species, including
isolated 2G12 (Fab)2, were calculated (Figure 5). In many of the
classes for 2G12 dimer and higher-order oligomers, the 2G12
(Fab)2 was discernable and the Fc less clear. The classes corre-
sponding to the dimer and trimer were consistent with an inter-
molecular domain swapping model as deduced from the crystal
structures. The lack of well-defined class averages for 2G12
IgGs in comparison to a 2G12 (Fab)2 alone (Figure 5A) suggested
that 2G12 IgG monomers, dimers, and trimers are flexible struc-
tures (Figures 5B–5D). In the case of 2G12 monomer, the flexi-
bility presumably resulted solely from the connection between
the Fc and the rigid (Fab)2 unit, whereas the 2G12 multimers
could adopt different positions of their (Fab)2 units with respect
to their Fc regions and each other. Attempts to generate 3D re-
constructions of these particles produced maps that were diffi-
cult to interpret, also indicative of conformational heterogeneity.
To assess the similarity of the 2G12 IgG dimer models analyzed
via crystallography and negative-stain EM, the crystal structure
of dimer A (Figures 2B and 3A) was filtered to 25 A˚ and back pro-
jected at a 20 Euler angle sampling (Figure 5E). The back projec-
tions of 2G12 dimer A showing different orientations of the two
(Fab)2 pairs with respect to the Fcs consistently matched the
independently generated EM class averages of the 2G12 dimer.
Small-angle X-ray scattering (SAXS) data collected on the 2G12
IgG dimer were also consistent with the dimensions and flexi-
bility observed by EM (Figures 5 and S5; Supplemental Experi-
mental Procedures).
2G12 Dimer Binds Bivalently to Antigens and Has Fully
Accessible Fc Regions
The crystal structures, single-particle EM images, and SAXS
analyses of 2G12 dimer suggested that the (Fab)2 units of the
IgG dimer are flexible with respect to the Fc region, analogous
to the two Fab arms of a conventional IgG antibody. If so, then
like a conventional IgG, 2G12 dimer should be capable of biva-
lent binding to a tethered antigen. By contrast, the intramolecular
domain exchange in 2G12 monomer results in a rigid structure
that does not have two independently movable Fab arms for
bivalent binding (Figure 1B). Rather, the (Fab)2 unit behaves as
a single unit using its conventional combining sites at the VH/VL
interfaces plus the site created by the domain-swapped VH/VH
0
region to bind to clusters of glycans (Calarese et al., 2003) and
should therefore exhibit apparently monovalent binding. To
verify these predictions, we compared the binding of 2G12
dimer, 2G12 monomer, and conventional anti-gp120 IgGs to a
clade B gp120 using a surface plasmon resonance binding
assay. 2G12 monomer, 2G12 dimer, or monomeric anti-gp120
IgGs (NIH45-46G54W and 2909; Diskin et al., 2011; Gorny et al.,hors
Figure 5. Negative-Stain EM of 2G12 Oligomers
(A) Representative two-dimensional class averages (left) and false-colored images (right) of 2G12 (Fab)2, 2G12 monomer, 2G12 dimer, and 2G12 trimer showing
the orientations of the domain-swapped (Fab)2 units and the Fc regions. Fabs are colored in cyan and Fcs in yellow. The scale bar represents 10 nm.
(B–D) 2D class averages of 2G12 oligomers analyzed by negative-stain EM. The scale bar represents 10 nm. Panels of 64 class averages of the (B) 2G12
monomer, (C) 2G12 dimer, and (D) 2G12 trimer generated using reference-free Xmipp Clustering 2D alignment.
(E) Back projections sampled at 20 Euler angles of the low-pass-filtered 2G12 dimer A crystal structure. The scale bar represents 10 nm. Many of the back
projections resembled the reference-free class averages of the 2G12 IgG dimer in (C).
See also Figure S5 for SAXS data supporting the EM and crystallographic results.
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Figure 6. Surface Plasmon Resonance Based Binding Studies
Sensorgrams were derived from binding experiments in which 2G12 monomer, 2G12 dimer, or a conventional monomeric anti-gp120 IgG was injected over
immobilized gp120 from HIV-1 strain SF162. Experimental data (colored lines) were fit to a 1:1 binding model (black lines). Residual plots are shown in Figure S6.
(A) 2G12 monomer, 2G12 dimer, and a conventional anti-gp120 IgG (NIH45-46G54W) injected over gp120 immobilized at high coupling density (100 RU). 2G12
monomer, but not 2G12 dimer or the conventional IgG, could be fit to a 1:1 binding model.
(B) 2G12monomer, 2G12 dimer, and a conventional anti-gp120 IgG (NIH45-46G54W) injected over gp120 immobilized atmedium coupling density (50 RU). 2G12
monomer, but not 2G12 dimer or the conventional IgG, could be fit to a 1:1 binding model.
(C) 2G12 monomer, 2G12 dimer, and a conventional anti-gp120 IgG (2909) injected over gp120 immobilized at low coupling density (<10 RU). All could be fit to a
1:1 binding model.2005) were injected over a gp120 protein from the clade B SF162
strain that was immobilized on the surface of a biosensor chip.
The gp120 protein was coupled at high and medium coupling
densities to permit bivalent binding and at a low density to reveal
the potential loss of bivalent binding when the (Fab)2 arms of
2G12 dimer or the Fab arms of the conventional anti-HIV-1
IgGs could not crosslink between two gp120 molecules. To
distinguish between monovalent and bivalent binding, we fit
the sensorgram data to a 1:1 binding model and assessed the
residuals for the goodness of fit (Figures 6 and S6). We found
that 2G12 monomer exhibited apparently monovalent binding
to gp120 at all coupling densities (Figures 6A–6C). As predicted,
2G12 dimer exhibited apparently bivalent binding to gp120 at
high and medium coupling densities (Figures 6A and 6B) but
monovalent binding at low coupling density (Figure 6C). Conven-
tional anti-gp120 IgGs bound with apparent bivalency at high
coupling density but monovalently at medium and low densities,
suggesting a smaller reach between combining sites than 2G12
dimer (Figures 6A–6C).
The 2G12 dimer structures suggested that the CH2-CH3
domain interface, the binding site for the neonatal Fc receptor
(FcRn) (Burmeister et al., 1994), and the site of contacts that1450 Cell Reports 5, 1443–1455, December 12, 2013 ª2013 The Autform the NCS 6-fold axis (Figures 2C, 3C, and S3B) would be
accessible for potential interactions. Two FcRn proteins bind
to the Fc region of a conventional IgG monomer: one per poly-
peptide chain in the Fc (Huber et al., 1993; Sa´nchez et al.,
1999). Because 2G12 dimer contains two Fc regions with four
potential FcRn binding sites, up to four FcRn proteins could
bind per 2G12 dimer. To characterize the binding interaction
between FcRn and 2G12 dimer, we used equilibrium gel filtra-
tion, a technique that can be used to determine the stoichiometry
of a complex that might dissociate during conventional gel-filtra-
tion chromatography (Hummel and Dreyer, 1962; Sa´nchez et al.,
1999; West and Bjorkman, 2000). For the 2G12 experiments, a
gel-filtration column was equilibrated with a buffer containing
5 mM FcRn, a concentration 10-fold higher than the KD of the
interaction between FcRn and IgG in solution (Huber et al.,
1993). We then injected various ratios of FcRn to 2G12monomer
or dimer. In both chromatograms in Figure 7, the first peak
corresponded to the 2G12 complex with FcRn, which migrated
at an apparently higher molecular mass for the dimer complex
than for the monomer complex. Both chromatograms also
showed a peak or a trough at the position where unbound
FcRn migrated: a peak in the case of the 3:1 ratio of FcRn perhors
Figure 7. Equilibrium Gel-Filtration Analyses of FcRn-2G12
Complexes
(A) FcRn was incubated with 2.5 mM 2G12 monomer in the presence of 0, 1, 2,
or 3 (additional) equivalents of FcRn in a buffer containing 5 mM FcRn (equili-
bration buffer). Samples were then injected onto a column equilibrated in the
equilibration buffer. The peak that eluted first corresponded to an FcRn-2G12
monomer complex. The second peak or trough was at the elution volume of
free FcRn.
(B) FcRn was incubated with 1.25 mM 2G12 dimer in the presence of 0, 2, 4,
or 6 (additional) equivalents of FcRn in a buffer containing 5 mM FcRn
(equilibration buffer). Samples were then injected onto a column equilibrated
in the equilibration buffer. The peak that eluted first corresponds to an FcRn-
2G12 dimer complex. The second peak or trough was at the elution volume
of free FcRn.Fc region in 2G12 monomer and the 6:2 ratio of FcRn per Fc
region in 2G12 dimer (indicating excess FcRn) and troughs in
the cases of lower ratios of FcRn per Fc. Because excess
FcRn was present when a 3:1 (or 6:2) ratio of FcRn per Fc was
injected, the stoichiometry for both complexes is two FcRn pro-
teins bound per Fc region. Thus, two FcRn molecules were
bound per 2G12 monomer, which contains one Fc region, and
four FcRn molecules were bound per 2G12 dimer, which con-
tains two Fc regions.Cell ReDISCUSSION
Among known broadly neutralizing HIV-1 antibodies, 2G12 is
unusual in two respects: first, it recognizes a carbohydrate
epitope on gp120 (Botos and Wlodawer, 2005), and second,
its Fab arms are domain swapped to form a rigid single (Fab)2
unit (Calarese et al., 2003). We hypothesized that intermolecular
domain swapping could create a dimeric species of 2G12 IgG
that was observed by size-exclusion chromatography (West
et al., 2009). Compared with 2G12 monomer, purified 2G12
dimer is 50- to 80-fold more potent in in vitro neutralization
assays (West et al., 2009), more effective in protection from
HIV infection in in vivo experiments (Luo et al., 2010), and medi-
ates ADCC at lower concentrations (Klein et al., 2010). The pre-
sent structural studies were initiated to investigate the structural
mechanism for the increased activity of 2G12 dimer versus
monomer.
Although crystal structures of intact IgGs are rare, with few ex-
amples in the literature (Guddat et al., 1993; Harris et al., 1997,
1998; Kratzin et al., 1989; Saphire et al., 2001), intact 2G12 IgG
dimer formed crystals, both alone and complexed with the
2G12.1 inhibitor peptide. Both crystal forms diffracted weakly
to low resolution, but we could solve crystal structures bymolec-
ular replacement for 2G12 dimer and the 2G12 dimer/2G12.1
complex at resolutions between 6.5 and 8 A˚ and verify the struc-
tures by heavy-atommethods and native Patterson calculations.
The low-resolution structures revealed three distinct confor-
mations of 2G12 dimer. In each conformation, the two (Fab)2
units in the dimer were arranged as arms at an obtuse angle,
analogous to the Fab arms of a conventional IgG monomer
that can bind bivalently to tethered antigens. The two Fc regions
were separated from each other, suggesting they would not
block each other’s interactions with Fc receptors. Indeed,
2G12 dimer interactedwith FcRnwith proportional stoichiometry
as 2G12 monomer in equilibrium gel-filtration studies, corrobo-
rating the idea that Fc regions in 2G12 dimer are as accessible
for effector functions as the Fc regions in conventional IgGs.
2D class averages from negative-stain electron microscopy pro-
vided unbiased, reference-free profiles that confirmed the flexi-
bility and orientations of the 2G12 dimers observed in crystal
structures. The presence of three distinct conformations of
2G12 dimer indicated that different conformational intermedi-
ates were trapped in the two crystal forms. Consistent with this
suggestion, 2G12 dimer could bind bivalently to immobilized
gp120, allowing avidity effects to increase the apparent affinity
of 2G12 dimer for its carbohydrate epitope. By contrast, the
single rigid (Fab)2 unit of monomeric 2G12 bound monovalently
to immobilized gp120, regardless of the density of the gp120
on the surface.
These results are relevant to a hypothesis that a general
inability of many HIV-1 antibodies to bind with avidity is one
reason that the antibody response against HIV-1 is generally
ineffective (Klein and Bjorkman, 2010). Briefly, we proposed
that most Env antibodies do not bind bivalently to HIV-1 spike
trimers because (1) the small number and low density of HIV
spike trimers does not normally permit interspike crosslinking
and (2) the distance between the same epitope on individual
monomers within a spike trimer usually exceeds the armspanports 5, 1443–1455, December 12, 2013 ª2013 The Authors 1451
of a conventional IgG, thereby preventing most instances of
intraspike crosslinking (Bartesaghi et al., 2013; Julien et al.,
2013; Lyumkis et al., 2013). To assess potential bivalent binding
by antiviral IgGs, we defined the molar neutralization ratio (MNR)
as the concentration at which a Fab achieves 50% inhibition of
viral infectivity (IC50) divided by the IC50 for the parental IgG in
an in vitro neutralization assay. An antibody that is unable to
bind with avidity would exhibit an MNR of two, because the
IgG has twice the amount of antigen-binding capacity as the
Fab. MNRs greater than two suggest avidity effects resulting
from the IgG crosslinking epitopes on the virus. Results from
published studies showed highMNRs for antibodies against res-
piratory syncytial virus and influenza (Edwards and Dimmock,
2001; Schofield et al., 1997; Wu et al., 2005), suggesting that
antibodies can take advantage of avidity effects to bind to envel-
oped viruses other than HIV-1. However, a compilation of the
highest-reported MNRs for antibodies against HIV showed that
neutralizing antibodies yielded relatively low MNRs (Klein and
Bjorkman, 2010).
Although the (Fab)2 unit of monomeric 2G12 interacts with at
least three high-mannose glycans, the binding surface is a single
unit; thus, the 2G12monomer does not have the capacity to bind
antigen with avidity as it is conventionally defined. However,
2G12 dimer can be up to 2,500-fold more potent in neutralization
than monomeric 2G12 on a molar basis (West et al., 2009); thus,
the high MNRs for 2G12 dimer compared to its monomeric form
are similar to the large effects seen for conventional IgGs against
non-HIV viruses (Klein and Bjorkman, 2010). The discovery that
2G12 dimer is a flexible molecule that behaves like an oversized
version of a conventional IgG antibody now allows us to postu-
late that avidity effects, rather than simply doubling the surface
area of a single combining site, account for the mechanism by
which 2G12 dimer achieves its greater potency compared with
2G12 monomer.
The 2G12 dimer structure, taken together with what is known
about the 2G12 epitope, permits speculation as to its mode of
binding with avidity to HIV spike trimers. 2G12 has been re-
ported to bind to a specific high-mannose patch on gp120
that has been called ‘‘intrinsic’’ due to its conserved and unusual
avoidance of a-mannosidase processing while being trafficked
through the endoplasmic reticulum and Golgi (Bonomelli et al.,
2011). We propose that one of the (Fab)2 units of 2G12 dimer
first tethers with high affinity to the intrinsic mannose patch
before sampling the abundant high-mannose landscape in the
surrounding glycan shield for a second binding opportunity.
Because the intrinsic mannose patch on an adjacent gp120
monomer within a spike trimer would be too far away to be
reached by the second (Fab)2 unit of 2G12 dimer, we believe
that the second 2G12 ‘‘epitope’’ would be a suboptimal glycan
cluster distinct from the intrinsic mannose patch. The finding
that 2G12 dimer binds monovalently to immobilized gp120
coupled at low density suggests that two (Fab)2 units cannot
bind simultaneously to a single gp120; thus, the suboptimal sec-
ond epitope would likely be on an adjacent gp120 within a spike
trimer.
Our studies provide important information for therapeutic anti-
HIV efforts in that they provide a direct demonstration of the
importance of avidity in HIV-1 neutralization. Here, we show a1452 Cell Reports 5, 1443–1455, December 12, 2013 ª2013 The Autcomparison of the structures of a monomeric and dimeric form
of a carbohydrate-only HIV-1 antibody. Unlike HIV-1 antibodies
for protein-only epitopes, the dimeric form of 2G12 can take
advantage of avidity to increase its neutralization potency and
breadth, thus is a promising candidate for therapeutic efforts
to combat HIV-1. Despite initially discouraging results with
less-potent antibodies (Poignard et al., 1999), passive delivery
of antibodies has been gaining new attention (reviewed in Klein
et al. [2013]), with encouraging results from a cocktail of three
or five broadly neutralizing antibodies in humanized mice in-
fected with HIV-1 (Diskin et al., 2013; Klein et al., 2012). 2G12
dimer would be very effectively employed in such a cocktail, as
it shares its primary epitope with no other known antibody and
can potentially exploit surrounding glycans as a secondary
epitope. Of direct relevance to potential therapeutic use of anti-
bodies for passive immunotherapy, bivalent binding can serve as
a buffer against Env mutations (Klein and Bjorkman, 2010); thus,
2G12 dimer is a good candidate for therapeutic efforts against
clade A and clade B HIV strains.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
2G12 IgG was expressed in transiently transfected human embryonic kidney
293-6E suspension cells as described (West et al., 2009). A mixture of 2G12
monomer and dimer was isolated from harvested supernatants by FcRn
affinity chromatography (Huber et al., 1993) using 5 ml of HiTrap N-hydroxy-
succinimide-activated resin (GE Healthcare) coupled to 12 mg of rat FcRn.
Supernatants were loaded on the FcRn column in 250 mM MES, 150 mM
NaCl, 0.02% sodium azide, pH 5.7, and eluted in 250 mM HEPES, 150 mM
NaCl, 0.02% NaN3, pH 8. The eluent was subjected to size-exclusion chroma-
tography in 20 mM Tris pH 8.0, 150 mMNaCl using a Superdex 200 16/60 gel-
filtration column (GE Healthcare). Fractions corresponding to 2G12 dimer or
monomer were pooled and subjected to SEC an additional two times. Further
experimental details, including crystallization of 2G12 dimer and X-ray data
collection, are in the Supplemental Experimental Procedures.
Data Processing and Structure Determination
Diffraction data were processed using XDS (Kabsch, 2010) or HKL2000 (Otwi-
nowski and Minor, 1997) and were indexed, integrated, and scaled using
POINTLESS and SCALA. Rather than Rmerge statistics, we used a combination
of CC1/2 in the range of 90% (Karplus and Diederichs, 2012) and I/s > 1.5 in
the highest resolution shell to determine the resolution cutoffs for our data
sets. Data for 2G12 dimer were corrected for anisotropy using the University
of California, Los Angeles (UCLA)-Molecular Biology Institute (MBI) Anisotropy
Server (Strong et al., 2006). Molecular replacement was carried out using
Phaser-MR (McCoy et al., 2007; Winn et al., 2011) and Molrep (Lebedev
et al., 2008; Vagin and Teplyakov, 2010; Winn et al., 2011). All molecular-
replacement solutions in space group P6122 yielded higher translation func-
tion Z-scores (ten and above for initial placement of three (Fab)2 units) as
well as lower initial R factors (0.54 versus over 0.60) than solutions in the enan-
tiomeric space group P6522. Native Patterson calculations were done using
POLARRFN (Winn et al., 2011) in the UCLA-MBI Self Rotation Function Server,
sfall (Winn et al., 2011), and Patterson (Winn et al., 2011). Rigid-body refine-
ment and domain B factor refinement were carried out using CNS (Brunger,
2007; Bru¨nger et al., 1998) or Phenix.refine (Adams et al., 2010). Model and
electron density visualizations were done using COOT (Emsley et al., 2010)
and PyMol (Schro¨dinger). Map truncation was done using Phenix.map_box
(Adams et al., 2010). Structure figures were prepared using PyMol. Globular
structures in Figures 3, 4, and S4 were prepared by conversion of coordinate
files into 25 A˚ mrc map volumes using pdb2mrc in the EMAN2.0 suite (Tang
et al., 2007), which were then rendered in UCSF Chimera (Pettersen et al.,
2004).hors
EM
2G12 species purified via SEC were analyzed by negative-stain EM. A 3 ml
aliquot of 1–2.5 mg/ml of 2G12 (Fab)2 or 2G12 monomer, dimer, or trimer
was applied to a freshly glow-discharged carbon-coated 400 Cu mesh grid
and stained with 2% uranyl formate for 20 s. Grids were imaged using a FEI
Tecnai T12 electron microscope operating at 120 kV at 52,0003magnification
and electron dose of 25 e/A˚2, which resulted in a pixel size of 2.05 A˚ at the
specimen plane. Images were acquired with a Tietz 4k 3 4k charge-coupled
device camera using LEGINON (Suloway et al., 2005) at a defocus range of
700–1,000 nm.
Particles were picked automatically using DoG Picker and put into a particle
stack using the Appion software package (Lander et al., 2009; Voss et al.,
2009). Initial reference-free 2D class averages were calculated using unbinned
particles via the Xmipp Clustering 2D Alignment and sorted into classes (Sor-
zano et al., 2010). Particles corresponding to only 2G12 species were selected
into a substack, and another round of reference-free alignment was carried out
using Xmipp Clustering 2D Alignment and IMAGIC softwares to generate 64
classes (van Heel et al., 1996). A total of 6,583, 10,341, and 4,230 particles
went into the final 2D classes of the monomer, dimer, and trimer, respectively.
Back projections of 2G12 IgG dimer A were calculated using EMAN software
(Tang et al., 2007) as follows: the X-ray coordinates were converted from PDB
toMRC format using pdb2mrc, low-pass filtered to 25 A˚ resolution to generate
a density map, and the map was projected at 20 Euler angle increments using
project3d and displayed in e2 display.
Biosensor Studies of 2G12 Interactions with gp120
A Biacore T200 biosensor system (GE Healthcare) was used to evaluate the in-
teractions of 2G12 monomer, 2G12 dimer, and control gp120 antibodies
NIH45-46G54W (Diskin et al., 2011) and 2909 (Gorny et al., 2005) with recombi-
nant gp120 from the strain SF162 (gift of Leo Stamatatos, Seattle Biomed).
Response units (RUs) of gp120 ranging from fewer than ten to approximately
100 were covalently immobilized on flow cells of CM5 biosensor chips using
standard primary amine-coupling chemistry (Biacore T200manual, GEHealth-
care). A concentration series of either 2G12 monomer, dimer, or control anti-
gp120 IgG was injected at 25C in 10 mM HEPES with 150 mM NaCl, 3 mM
EDTA, and 0.005% (v/v) surfactant P20 at pH 7.4. Sensor chips were regener-
ated using 10 nM glycine, pH 2.5. After subtracting the signal from the refer-
ence flow cell, we globally fit the kinetic data from each experiment to a 1:1
bindingmodel (Biacore evaluation software). When an obvious refractive index
change occurred when switching from the association to the dissociation
buffer, the sensorgrams were also fit with a refractive index correction (third
row, middle panel of Figures 6 and S6). We evaluated the fit to the 1:1 binding
model of each binding interaction by calculating and plotting residuals
between the experimental and modeled curves.
Equilibrium Gel Filtration
Equilibrium gel-filtration chromatography (Hummel and Dreyer, 1962) was per-
formed to determine the stoichiometry of the association of 2G12 monomer
and 2G12 dimer with FcRn. Briefly, chromatography was performed at a
flow rate of 100 ml/min using a SMART micropurification system (Pharmacia)
monitoring the absorbance at 280 nm. The experiment was run on a Superdex
200 PC 3.2/30 gel-filtration column, which was equilibrated with and run in
equilibrium buffer (10 mM PIPES, 0.05% sodium azide, pH 6.1) containing
5 mM soluble FcRn. All IgG samples and various concentrations of FcRn
were buffer exchanged into the PIPES buffer via dialysis prior to injection
over the column. We mixed 2.5 mM of 2G12 monomer with equilibration buffer
containing 5 mM FcRn plus no additional FcRn, 2.5 mM additional FcRn, 5 mM
additional FcRn, or 7.5 mM additional FcRn. We mixed 1.25 mM of 2G12 dimer
with equilibration buffer containing 5 mMFcRn plus no additional FcRn, 2.5 mM
additional FcRn, 5 mM additional FcRn, or 7.5 mM additional FcRn.
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